Tuesday, October 21, 2014 12:11:04 PM
The delay in providing Private Placement detail / information to the Shareholder at a critical time combined with the subsequent explanation as to why it had not be provided earlier.
The $50,000 referenced in section 16 of the Regulation D filing on 10/16/14 and the subsequent reasoning as to why it was presented in that manner.
These three items, and maybe more importantly the content / context of the subsequent explanations, cost a bit of built up good will Capital to be expended.
I understand what the Company is providing in the PR s. I am offering my opinion as to why potential Buyers may be taking a wait and see position.
As for slowed momentum there is no meaningful Volume, Agressive / accumulating Buying is missing - etc.
My opinion.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM